Selected article for: "acute disease and adjuvant therapy"

Author: Maideen, Naina Mohamed Pakkir
Title: Prophetic Medicine-Nigella Sativa (Black cumin seeds) – Potential herb for COVID-19?
  • Cord-id: 8cvj4wdp
  • Document date: 2020_6_30
  • ID: 8cvj4wdp
    Snippet: Coronavirus disease-19 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS CoV-2). Currently, the management of patients with COVID-19 depends mainly on repurposed drugs which include chloroquine, hydroxychloroquine, lopinavir/ritonavir, ribavirin, remdesivir, favipiravir, umifenovir, interferon-α, interferon-β and others. In this review, the potential of Nigella sativa (black cumin seeds) to treat the patients with COVID-19 analyzed, as it has shown to possess an
    Document: Coronavirus disease-19 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS CoV-2). Currently, the management of patients with COVID-19 depends mainly on repurposed drugs which include chloroquine, hydroxychloroquine, lopinavir/ritonavir, ribavirin, remdesivir, favipiravir, umifenovir, interferon-α, interferon-β and others. In this review, the potential of Nigella sativa (black cumin seeds) to treat the patients with COVID-19 analyzed, as it has shown to possess antiviral, antioxidant, anti-inflammatory, anticoagulant, immunomodulatory, bronchodilatory, antihistaminic, antitussive, antipyretic and analgesic activities. PubMed, Google Scholar, Science Direct, Directory of open access journals (DOAJ) and reference lists were searched to identify articles associated with antiviral and other properties of N.sativa related to the signs and symptoms of COVID-19. Various randomized controlled trials, pilot studies, case reports and in vitro and in vivo studies confirmed that N.sativa has antiviral, antioxidant, anti-inflammatory, immunomodulatory, bronchodilatory, antihistaminic, antitussive activities related to causative oraganism and signs and symptoms of COVID-19. N. sativa could be used as an adjuvant therapy along with repurposed conventional drugs to manage the patients with COVID-19.

    Search related documents:
    Co phrase search for related documents
    • active ingredient and adjuvant therapy: 1
    • active ingredient and lopinavir ritonavir: 1
    • activity score and liver function: 1
    • adjuvant therapy and liver function: 1, 2
    • adjuvant therapy and lmwh weight heparin: 1
    • adjuvant therapy and lopinavir ritonavir: 1
    • adjuvant therapy and low molecular lmwh weight heparin: 1
    • liver function and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
    • lmwh treatment dose and low molecular lmwh weight heparin: 1, 2, 3
    • lmwh weight heparin and lopinavir ritonavir: 1, 2, 3
    • lmwh weight heparin and low molecular lmwh weight heparin: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • lopinavir ritonavir and low molecular lmwh weight heparin: 1, 2, 3